We are live on ! Find out more
PS

Peter Svennilson Portfolio holdings

AUM $1.23B
1-Year Est. Return 301.34%
This Fund
S&P 500
This Quarter Est. Return
-15.48%
1 Year Est. Return
+301.34%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$113M
AUM Growth
Cap. Flow
+$140M
Cap. Flow %
123.64%
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 92.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRTS
1
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$47.9M 42.25%
+3,102,934
New +$59.2M
RCUS icon
2
Arcus Biosciences
RCUS
$3.55B
$38.1M 33.61%
+3,540,850
New +$41.3M
CNST
3
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$18.8M 16.53%
+4,677,938
New +$28.2M
IMDZ
4
DELISTED
Immune Design Corp.
IMDZ
$8.64M 7.61%
+6,642,942
New +$11.5M

Similar funds

Peter Svennilson's Q4 2018 Portfolio in Review

Q4 2018 is the first quarter with a 13F filing on record for Peter Svennilson, which disclosed 4 positions worth $113M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Gritstone bio, Inc. Common Stock: 3,102,934 shares worth $47.9M.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets.

  • Peter Svennilson's largest Q4 2018 buy was Gritstone bio, Inc. Common Stock: 3,102,934 shares worth $47.9M.
  • Peter Svennilson's ten largest holdings make up 100% of its $113M portfolio in Q4 2018.
  • Peter Svennilson disclosed 4 positions in Q4 2018, its first 13F filing on record.

Based on Peter Svennilson's 13F filing for Q4 2018, filed 13 Feb 2019.